We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Drug Development Meetings

Drug Development Meetings

June 8, 2006

Join FDAnews Thursday, June 22, for "Corrective and Preventive Action Systems: Leverage Data From the FDA's Own CAPA Training Program." In this 90-minute audioconference with Q&A session, former FDA investigator Martin Browning will focus on data taken directly from the FDA's own CAPA training program. He will discuss regulatory expectations and the real benefits of an effective CAPA system. On June 27, join FDAnews for "Preparing for an FDA Preapproval Inspection." In this 90-minute audioconference, 34-year FDA veteran Bill Ment will show you how to prepare for and manage preapproval inspections to avoid misunderstandings, prevent delays in the approval process and eliminate unnecessary costs.

June 12-13: Auditing Techniques for Clinical Research Professionals Edison, N.J. (610) 548-2200 Barnett Educational Services customer.service@parexel.com

www.barnettinternational.com/index-flash.html

June 12-13: Conducting Clinical Trials Under ICH GCP San Diego, Calif. (610) 548-2200 Barnett Educational Services customer.service@parexel.com www.barnettinternational.com/index-flash.html

June 12-13: Writing for Clinical Research Boston, Mass. (610) 548-2200

Barnett Educational Services customer.service@parexel.com www.barnettinternational.com/index-flash.html

June 13-15: Drug Discovery & Development China Shanghai, China 65 68355 107 IBC Asia (S) Pte Ltd Lynn.Ng@ibcasia.com.sg www.drugdisc.com

June 15-16: Monitoring Clinical Drug Studies: Intermediate Chicago, Ill. (610) 548-2200 Barnett Educational Services customer.service@parexel.com www.barnettinternational.com/index-flash.html

June 19-20: Drug Development and FDA Regulations Boston, Mass. (610) 548-2200

Barnett Educational Services customer.service@parexel.com www.barnettinternational.com/index-flash.html

June 20-21: Complying with the EU Clinical Trial Directive Boston (212) 661-3250 PTi international dweinberg@pti-international.com www.pti-international.com

June 22-23: ADME, PK/TK, and Drug Metabolism in Drug Discovery and Development Irvine, Calif. (610) 688-1708 The Center for Professional Innovation and Education

info@cfpie.com www.cfpie.com/showitem.aspx?productid=090&source=fdanewsconferencecalendarfree

June 26-27: Clinical Trials in Cancer London, UK +44 (0)20 7827 6088 SMi Group Ltd dmorgan@smi-online.co.uk www.smi-online.co.uk/ctcancer.asp

June 29-30: Clinical Statistics for Non Statisticians Amsterdam, the Netherlands

(215) 442-6100 Drug Information Association dia@diahome.org www.diahome.org

June 29-30: Project Management in Drug Development: Phase I and Phase II Clinical Development

Philadelphia, Pa. (212) 661-3500 PTi international dweinberg@pti-international.com

www.pti-international.com

July 10-11: Trial Design Innovation Washington, D.C . (212) 400-6240 ExL Pharma fcasanova@exlpharma.com www.exlpharma.com/index.php

KEYWORDS Drug Pipeline Alert

Upcoming Events

  • 01Feb

    The Future of QMS: Will the Recent Announcement and Delays Have a Global Impact?

  • 08Feb

    Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions

  • 09Feb

    The Inextricable Link Between Data Integrity and Quality Culture

  • 15Feb

    Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 22Feb

    Best Practices for Developing and Maintaining a GxP Training Matrix

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • NeuroMetrix Launches DPNCheck 2.0 for Peripheral Neuropathy Screening

  • Syros Gets Fast Track Status for Higher-Risk Myelodysplastic Syndrome Candidate

  • FDA Approves Abbott’s Spinal Cord Stimulation System for Diabetic Peripheral Neuropathy

  • FDA Expands Approval for Merck’s Keytruda in NSCLC

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing